Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a fast-growing cancer of the blood and bone marrow that results in the overproduction of immature white blood cells, leading to symptoms like fatigue, frequent infections, and easy bruising.
Acute Myeloid Leukemia: MB-dNPM-1-TCR.1 Treatment
We are studying a new therapy for patients with relapsed or refractory acute myeloid leukemia. The goal is to understand its safety and how well it works compared to existing treatments.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Academisch Ziekenhuis Leiden
Department of Hematology
Leiden, Netherlands
Sponsor: Miltenyi Biomedicine GmbH
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.